Strata Critical Medical (SRTA) Return on Invested Capital (2021 - 2026)

Strata Critical Medical has disclosed Return on Invested Capital across 7 years of filings, most recently posting 0.0% for Q1 2026.

• In Q1 2026, Return on Invested Capital changed 0.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), while the FY2023 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital grew to 0.0% in Q1 2026, from 0.0% in the prior quarter.
• Over the last five years, Return on Invested Capital for SRTA reached as high as 0.0% in Q1 2026 and fell as low as 0.0% in Q3 2024.
• The 5-year median for Return on Invested Capital is 0.0% (2023), against an average of 0.0%.
• The widest YoY moves for Return on Invested Capital: up 0 bps in 2023, down 0 bps in 2023.
• A 5-year view of Return on Invested Capital shows it stood at 0.0% in 2022, then tumbled by 122 bps to 0.0% in 2023, then jumped by 42 bps to 0.0% in 2024, then soared by 47 bps to 0.0% in 2025, then climbed by 12 bps to 0.0% in 2026.
• According to Business Quant data, Return on Invested Capital over the past three periods registered 0.0%, 0.0%, and 0.0% for Q1 2026, Q4 2025, and Q3 2025 respectively.